Type of Cancer
Head and Neck
Phase
Division (Location)
Study ID
NCT#
Brief Description
PHASE 1, OPEN-LABEL, DOSE-FINDING STUDY OF CC-90009, A NOVEL CEREBLON E3 LIGASE MODULATING DRUG, IN SUBJECTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.